25 related articles for article (PubMed ID: 11858735)
1. Retinoic acid regulation by CYP26 in vertebrate lens regeneration.
Thomas AG; Henry JJ
Dev Biol; 2014 Feb; 386(2):291-301. PubMed ID: 24384390
[TBL] [Abstract][Full Text] [Related]
2. Application of synthetic photostable retinoids induces novel limb and facial phenotypes during chick embryogenesis in vivo.
Lopez-Real RE; Budge JJ; Marder TB; Whiting A; Hunt PN; Przyborski SA
J Anat; 2014 Apr; 224(4):392-411. PubMed ID: 24303996
[TBL] [Abstract][Full Text] [Related]
3. Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.
Goss PE; Strasser-Weippl K; Qi S; Hu H
BMC Cancer; 2007 Jan; 7():26. PubMed ID: 17266767
[TBL] [Abstract][Full Text] [Related]
4. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355
[TBL] [Abstract][Full Text] [Related]
5. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 1999 Sep; 159(2):109-16. PubMed ID: 10495774
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid receptor gamma-induced misregulation of chondrogenesis in the murine limb bud in vitro.
Galdones E; Hales BF
Toxicol Sci; 2008 Nov; 106(1):223-32. PubMed ID: 18703560
[TBL] [Abstract][Full Text] [Related]
7. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.
Wouters W; van Dun J; Dillen A; Coene MC; Cools W; De Coster R
Cancer Res; 1992 May; 52(10):2841-6. PubMed ID: 1581897
[TBL] [Abstract][Full Text] [Related]
8. Relation of TGF-beta 2 to inhibition of limb bud chondrogenesis by retinoid in rats.
Tsuiki H; Fukiishi Y; Kishi K
Teratology; 1996 Oct; 54(4):191-7. PubMed ID: 9122888
[TBL] [Abstract][Full Text] [Related]
9. Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acid.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 2002 Feb; 178(3):186-94. PubMed ID: 11858735
[TBL] [Abstract][Full Text] [Related]
10. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
Nau H
J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
[TBL] [Abstract][Full Text] [Related]
11. Experimental studies with liarozole (R 75,251): an antitumoral agent which inhibits retinoic acid breakdown.
De Coster R; Wouters W; Van Ginckel R; End D; Krekels M; Coene MC; Bowden C
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):197-201. PubMed ID: 1525060
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.
Miller WH
Cancer; 1998 Oct; 83(8):1471-82. PubMed ID: 9781940
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
